Vanda Pharmaceuticals Inc (VNDA) — Cash Flow Quality Index
Vanda Pharmaceuticals Inc (VNDA) has a Cash Flow Quality Index of -14.96x as of September 2023. Operating cash flow of $-2.05 Million is below net income of $137.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore VNDA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Vanda Pharmaceuticals Inc Cash Flow Quality Index (2010–2023)
Historical Cash Flow Quality Index for Vanda Pharmaceuticals Inc across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see VNDA cash generation efficiency.
Annual Cash Flow Quality Index for Vanda Pharmaceuticals Inc (2010–2023)
Year-by-year earnings quality comparison for Vanda Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | 5.10x | $12.80 Million | $2.51 Million | ▲ +0.1% |
| 2022 | 5.10x | $31.98 Million | $6.28 Million | ▲ +163.1% |
| 2021 | 1.94x | $64.21 Million | $33.15 Million | ▼ -12.7% |
| 2020 | 2.22x | $51.77 Million | $23.34 Million | ▲ +458.0% |
| 2019 | 0.40x | $45.95 Million | $115.55 Million | ▼ -66.6% |
| 2018 | 1.19x | $29.99 Million | $25.21 Million | ▲ +129.4% |
| 2014 | -4.04x | $-81.55 Million | $20.19 Million | ▼ -166.6% |
| 2010 | -1.52x | $-10.90 Million | $7.19 Million | — |